CLDN5 and neuromyelitis optica: Immunoblotting showed a significant 25.6% decrease in Claudin-5 expression in the presence of NMO-IgG1 compared to non-treated IBMs (p = 0.002), while it was not observed in the Control-IgG treated group (3.9%; non-significant) [U-Mann-Whitney test]).